Exploiting Mouse Models to Study Ras-Induced Cutaneous Squamous Cell Carcinoma

William E Lowry1, Aimee Flores2, Andrew C White3

  • 1Molecular Cell and Developmental Biology, University of California Los Angeles, Los Angeles, California, USA; Jonsson Comprehensive Cancer Center, University of California Los Angeles, Los Angeles, California, USA; Eli and Edythe Broad Center for Regenerative Medicine, University of California Los Angeles, Los Angeles, California, USA; Molecular Biology Institute, University of California Los Angeles, Los Angeles, California, USA.

Insights

New methods enable inducible delivery of cancer mutations to skin cells. Hair follicle stem cells can initiate squamous cell carcinoma, with molecular factors driving tumor diversity, offering insights into Ras-driven cancer.

Area of Science:

  • Dermatology
  • Oncology
  • Molecular Biology

Background:

  • Recent advancements allow inducible delivery of oncogenic mutations to specific epidermal cell types.
  • Understanding the cellular origins of squamous cell carcinoma (SCC) is crucial for developing effective treatments.
  • Oncogenic mutations in Ras are implicated in the development of SCC.

Purpose of the Study:

  • To summarize findings on the role of hair follicle stem cells (HFSCs) as cancer cells of origin in SCC.
  • To explore how molecular players contribute to tumor cell type heterogeneity in Ras-driven SCC.
  • To synthesize data providing insights into Ras-initiated SCC in human patients.

Main Methods:

  • Utilizing inducible genetic methods to deliver oncogenic mutations to epidermal cells.
  • Analyzing data from laboratory experiments and published studies.
  • Investigating the initiation and promotion roles of specific genetic alterations.

Main Results:

  • Hair follicle stem cells (HFSCs) can act as the cells of origin for SCC.
  • Various molecular factors drive the heterogeneity observed in tumor cell types.
  • Specific genetic mutations can function as either tumor initiators or promoters.

Conclusions:

  • HFSCs are capable of initiating squamous cell carcinoma.
  • Molecular mechanisms contribute significantly to the diversity of SCC tumor cells.
  • This research offers insights into Ras-driven SCC pathogenesis and potential therapeutic strategies.